期刊文献+

过敏性紫癜患儿血清胰岛素样生长因子及胰岛素样生长因子结合蛋白-3的变化 被引量:2

Serum levels of insulin-like growth factor-1 and insulin-like growth factor-binding potein-3 inHenoch-Scholdein purpura
原文传递
导出
摘要 目的探讨胰岛素样生长因子(IGF)-1及胰岛素样生长因子结合蛋白(]GFBP)-3在过敏性紫癜(HSP)中的作用。方法采用放射免疫法方法测定45例HSP患儿不同时期的血清IGF-1及IGFBP-3、C反应蛋白(CRP)水平。采用t检验和直线相关关系。结果HSP急性发作组血清IGF-1[(452±183)μg/L]、IGFBP-3[(13897±3]24)μg/L]及CRP[(20±8)mg/L]水平升高,与健康对照组和缓解组比较,差异均有统计学意义(f值分别为3.42、4.10、11.17、11.63、8.59、9.86,P均〈0.01);HSP缓解组血清IGF-1、IGFBP-3及CRP与健康对照组比较,差异无统计学意义(t=O.44、0.34、0.52,P均〉0.05)。HSP急性期并发肾损害组血清IGF-1[(621±253)μg/L]、IGFBP-3[(18763±3173)μg/L]水平升高,与无肾损害组比较,差异有统计学意义(t值分别为4-21、7.26,P均〈0.01),有胃肠道症组血清IGF-1[(479±192)μg/L]、IGFBP-3[(13986±3162)μg/L]水平与无胃肠道症状组比较,差异无统计学意义(t值分别为0.83、0.16,P均〉0.05);血清CRP水平在肾损害组与非肾损害组及胃肠道症组与无胃肠道症状组间差异均无统计学意义(t值分别为0.56、0.32,P均〉0.05)。HSP急性期患儿血IGF-l、IGFBP-3与CRP浓度之间呈直线正相关(r值分别为0.624,0.672,P均〈0.01)。结论IGF-1、IGFBP-3参与了HSP疾病的病理生理过程,血清IGF-1、IGFBP-3测定对紫癜性肾损害的诊断、病情监测及预后判断有一定帮助。 Objective To investigate the role of serum Insulin-like growth factor (IGF)-I, insulinlike growth factor-binding potein (IGFBP)-3 in children with Henoeh-Schonlein purpura (HSP). Methods The serum concentration of IGF-1, IGFBP-3 was measured by enzyme-linked immunosorbent assay (ELISA) method in 45 acute SHP patients, 40 recovery patients and 30 healthy controls. Results The serum levels of IGF-1 [ (452±183) μg/L], IGFBP-3 [ ( 13 897±3124)μg/L] and C-reactive protein (CRP) [ (20±8) mg/L] in acute phase were significantly higher than those in healthy controls (P〈0.01) and higher than those during recovery period. The serum level of IGF-1, IGFBP-3 for the HSP patients dropped back slowly and their levels during recovery period were the same as those in healthy controls (P〉0.05). The serum levels of IGF-1 [ (621±253) μg/L] and IGFBP-3 [ (18 763±3173) μg/L ] were higher in the renal damage group than in the non-renal damage group (P〈0.01), and the same in patients with gastrointestinal symptoms group as in patients without gastrointestinal symptoms group (P〉O.05), whereas the serum level of CRP was not signi- ficantly different (P〉0.05). The serum levels of IGF-1, IGFBP-3 showed positive correlation with the level of CRP (r=0.624, 0.672, P〈O.01 ). Conclusion The IGF-1 and IGFBP-3 may play an important role in the pathological mechanism of HSP. The level of IGF-1 may be used as an indicator for HSP disease activity and progression. IGF-1 may have a close relation with the damage of renal system in HSP.
出处 《中华风湿病学杂志》 CAS CSCD 北大核心 2011年第7期465-467,共3页 Chinese Journal of Rheumatology
基金 浙江省温岭市科技局基金(2007WLCA0050)
关键词 紫癜 过敏性 胰岛素样生长因子I 胰岛素样生长因子结合蛋白质3 C反应蛋白质 Purpura Schonlein-Henoch Insulin-like growth factor I Insulin-like growth factorbinding potein 3 C-reactive protein
  • 相关文献

参考文献7

  • 1蒋桂明.胰岛素样生长因子-1检测对糖尿病下肢血管病变的预测价值[J].重庆医科大学学报,2010,35(3):430-432. 被引量:3
  • 2Yildiz B, Kural N, Aydin B, et al. Increased serum levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3 in Henoch-Schonlein purpura. Tohoku J Exp Med, 2008, 214: 333-340.
  • 3鹿玲,邓芳,张琴,胡波,桂明,吴礼权.儿童过敏性紫癜901例临床分析[J].中华风湿病学杂志,2008,12(6):407-409. 被引量:11
  • 4Law HK, Tu W, Liu E, et al. Insulin-like growth factor I promotes cord blood T cell maturation through monocytes andinhibits their apoptosis in part through intedeukin-6. BMC Immunol, 2008, 17: 74.
  • 5Banerjee I, Clayton PE. Clinical utility of insulin-like growth factor- I (IGF- I ) and IGF binding protein-3 measurements in paediatric practice. Pediatr Endocrinol Rev, 2006, 3: 393- 402.
  • 6Vasylyeva TL, Ferry RJ Jr. Novel roles of the IGF- IGFBP axis netiopathophysiology of diabetic nephropathy. Diab Res Clin Prac, 2007, 76: 177-186.
  • 7Pr6vot A, Julita M, Tung DK, et al. Beneficial effect of insulin- like growth factor-1 on hypoxemic renal dysfunction in the newborn rabbit. Pediatr Nephrol, 2009, 24: 973-981.

二级参考文献18

  • 1辛朝晖,赵淑芝,王金来,孙雪梅,吕永锋.糖尿病与非糖尿病患者外周动脉病变超声检查对比研究[J].医学影像学杂志,2005,15(5):406-408. 被引量:8
  • 2何少为.儿童过敏性紫癜七例误诊分析[J].临床误诊误治,2006,19(9):38-39. 被引量:15
  • 3Butani L, Morgenstern BZ. Long-term outcome in children after Henoch-Schonlein purpura nephritis. Clin Pediatr, 2007,46: 505-511.
  • 4Gardner-Medwin JM, Dolezalova P, Cummins C, et al. Incidence of Henoch-Schonlein, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet, 2002, 360:1197- 1202.
  • 5Dolezalova P, Telekesova P, Nemcova D, et al. Incidence of vasculitis in children in the czech republic: 2-year prospective epidemiology survey. J Rheumatol , 2004, 31: 2295-2299.
  • 6Yang YH, Hung CF, Hsu CR, et al. A nationwide survey on epidemiological characteristics of childhood Henoch-Schonlein parpura in Taiwan. Rheumatology, 2005, 44: 618-622.
  • 7Tarshish P, Bernstein J, Edelmann CM. Henoch-Schonle in nephritis: course of disease and efficacy of cyclophosphamide. Pediatr Nephrol, 2004, 19: 51-56.
  • 8Al-Harbi NN. Henoch Schonlein nephritis complicated with pulmonary hemorrhage but treated successfully. Pediatr Nephrol, 2002,17: 762-764.
  • 9Wen YK, Yang Y, Chang CC. Cerebral vasculitis and intracerebral hemorrhage in Henoch Schonlein purpura treated with plasmapheresis. Pediatr Nephrol, 2005, 20: 223-225.
  • 10Ha TS, Lee JS. Serotal involvement in childhood Henoeh-Schonlein purpura. Acta Pediatr, 2007, 96: 552-555.

共引文献12

同被引文献21

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部